ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
85.00
+0.06 (+0.07%)
At close: 4:01PM EDT

84.86 -0.14 (-0.16%)
Pre-Market: 7:32AM EDT

Stock chart is not supported by your current browser
Previous Close84.94
Open85.36
Bid84.63 x 1800
Ask85.29 x 800
Day's Range84.40 - 85.36
52 Week Range60.32 - 85.36
Volume7,980,827
Avg. Volume5,193,223
Market Cap149.955B
Beta (3Y Monthly)0.85
PE Ratio (TTM)57.67
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.28 (1.51%)
Ex-Dividend Date2019-07-12
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Abbott Laboratories a Buy?
    Motley Fool5 days ago

    Is Abbott Laboratories a Buy?

    This stock hasn't delivered much excitement, just great returns.

  • How Do Rate Cuts Impact Healthcare Stocks?
    Market Realist5 days ago

    How Do Rate Cuts Impact Healthcare Stocks?

    Barclays expects the Fed to cut the rate by 50 basis points in July—three months earlier than previously expected. Barclays expects an additional rate cut by 25 basis points in September.

  • Abbott (ABT) Outpaces Stock Market Gains: What You Should Know
    Zacks6 days ago

    Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

    Abbott (ABT) closed at $83.42 in the latest trading session, marking a +1.67% move from the prior day.

  • Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers
    Zacks7 days ago

    Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers

    Abbott (ABT) gains from expansion of product portfolio and several regulatory clearances.

  • Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade
    Zacks11 days ago

    Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade

    Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

  • Traders Look to Buy Global Health Care Stocks
    Investopedia12 days ago

    Traders Look to Buy Global Health Care Stocks

    The patterns forming on the long-term charts suggest that the global health care sector could be poised for a prolonged move higher.

  • Here’s What Hedge Funds Think About Abbott Laboratories (ABT)
    Insider Monkey14 days ago

    Here’s What Hedge Funds Think About Abbott Laboratories (ABT)

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

  • The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life
    Zacks14 days ago

    The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life

    The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life

  • Markit14 days ago

    See what the IHS Markit Score report has to say about Abbott Laboratories.

    Abbott Laboratories NYSE:ABTView full report here! Summary * Perception of the company's creditworthiness is negative * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ABT with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ABT. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ABT totaled $4.38 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. ABT credit default swap spreads are at their highest levels for the past 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Where Will Abbott Laboratories Be in 10 Years?
    Motley Fool15 days ago

    Where Will Abbott Laboratories Be in 10 Years?

    Expect the healthcare giant to hew to the principles that lifted it to where it stands now.

  • Reuters16 days ago

    CORRECTED-Abbott device helps in cutting blood sugar in type 2 diabetics - study (June 8)

    Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc's continuous glucose monitoring system for three months compared with when they were not using the device, researchers said on Saturday. The study, which was presented at the American Diabetes Association meeting in San Francisco, assessed the medical records of 363 type 2 diabetics in France, Germany and Austria between three and six months. Dr. Helene Hanaire of the University Hospital Center of Toulouse, France, one of the study authors, said having ready access to their blood glucose readings helped diabetics become more engaged with controlling their glucose levels.

  • Top Research Reports for Mastercard, Disney & Abbott
    Zacks17 days ago

    Top Research Reports for Mastercard, Disney & Abbott

    Top Research Reports for Mastercard, Disney & Abbott

  • Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?
    Zacks18 days ago

    Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?

    Is (ABT) Outperforming Other Medical Stocks This Year?

  • Abbott (ABT) Gains But Lags Market: What You Should Know
    Zacks20 days ago

    Abbott (ABT) Gains But Lags Market: What You Should Know

    Abbott (ABT) closed at $77.54 in the latest trading session, marking a +1.85% move from the prior day.

  • Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges
    Zacks20 days ago

    Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges

    We are optimistic about the steady growth trend in Abbott's (ABT) EPD and Medical Devices segments on an organic basis.

  • Did Abbott Laboratories (NYSE:ABT) Use Debt To Deliver Its ROE Of 8.3%?
    Simply Wall St.21 days ago

    Did Abbott Laboratories (NYSE:ABT) Use Debt To Deliver Its ROE Of 8.3%?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Here is the 18th Most Popular Stock Among Hedge Funds
    Insider Monkey22 days ago

    Here is the 18th Most Popular Stock Among Hedge Funds

    Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the first […]

  • Abbott (ABT) Stock Moves -0.05%: What You Should Know
    Zacks26 days ago

    Abbott (ABT) Stock Moves -0.05%: What You Should Know

    In the latest trading session, Abbott (ABT) closed at $75.67, marking a -0.05% move from the previous day.

  • The Top Health Care Companies in the World
    Investopedia26 days ago

    The Top Health Care Companies in the World

    An introduction to health care companies that are tops in their fields. From health care provider to pharmaceuticals, these companies have the largest global presence according to market capitalization. Learn who these health care giants are and why they may be a good investment.

  • The highest-paid CEOs by state
    Associated Presslast month

    The highest-paid CEOs by state

    Here are the top paid CEOs by state for 2018, as calculated by The Associated Press and Equilar, an executive data firm. The survey considered only publicly traded companies with more than $1 billion in ...

  • CNBClast month

    One sector is making a comeback amid market volatility

    Prepare for more churn around these levels, said  Mark Tepper , president of Strategic Wealth Partners. "We're really trying to target good companies that are big players in investible themes, and health care as a sector has struggled this year but it's been resilient over the past month. As the S&P 500 has tumbled 4% this month, the XLV health care sector ETF has held slightly positive.

  • Abbott (ABT) Dips More Than Broader Markets: What You Should Know
    Zackslast month

    Abbott (ABT) Dips More Than Broader Markets: What You Should Know

    In the latest trading session, Abbott (ABT) closed at $75.64, marking a -0.81% move from the previous day.

  • 3 Dividend Aristocrats to Buy and Hold Forever
    Motley Foollast month

    3 Dividend Aristocrats to Buy and Hold Forever

    Stable businesses that dole out a regular paycheck are like a warm blankie for your portfolio.

  • Should Abbott Laboratories (NYSE:ABT) Be Part Of Your Dividend Portfolio?
    Simply Wall St.last month

    Should Abbott Laboratories (NYSE:ABT) Be Part Of Your Dividend Portfolio?

    Is Abbott Laboratories (NYSE:ABT) a good dividend stock? How would you know? Dividend paying companies with growing...